Results for reasonably related

Integra LifeSciences I Ltd. v. Merck KGaA

Case Number: CLB0169

Date: 07.27.2007

Preclinical research that is not included in an FDA submission can be exempt from patent infringement under 35 U.S.C. § 271(e)(1) if the drug maker has a reasonable basis for believing that the research, if successful, would be appropriate to include in an FDA submission.

view Case Detail Download PDF

Merck v. Integra Lifesciences

Case Number: CLB0077

Date: 06.13.2005

Preclinical research that is not included in an FDA submission can be exempt from patent infringement under 35 U.S.C. § 271(e)(1) if the drug maker has a reasonable basis for believing that the research, if successful, would be appropriate to include in an FDA submission.

view Case Detail Download PDF